Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.

导出原文传递

翻译打印收藏纠错

第一作者： P D,James

第一单位： Queen's University, Kingston, ON, Canada.

作者： P D,James ^[1] ; J,Mahlangu ^[2] ; C,Bidlingmaier ^[3] ; M E,Mingot-Castellano ^[4] ; M,Chitlur ^[5] ; P F,Fogarty ^[6] ; A,Cuker ^[6] ; M E,Mancuso ^[7] ; P A,Holme ^[8] ; J,Grabell ^[1] ; N,Satkunam ^[1] ; W M,Hopman ^[1] ; P,Mathew ^[9] ; Global Emerging HEmostasis Experts Panel (GEHEP)

作者单位： Queen's University, Kingston, ON, Canada. ^[1] Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. ^[2] Dr. von Hauner's Children's University Hospital, Munich, Germany. ^[3] Regional University Hospital of Malaga, Malaga, Spain. ^[4] Children's Hospital of Michigan, Detroit, MI, USA. ^[5] Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. ^[6] Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. ^[7] Department of Hematology and Institute of Clinical Medicine, University Hospital, University of Oslo, Oslo, Norway. ^[8] Bayer Health Care, Whippany, NJ, USA.;University of New Mexico, Albuquerque, NM, USA. ^[9]

关键词 ISTH-BAT bleeding haemophilia carriers